Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360442![]() (US9828369, Example 14 | ethyl 3-(8-((2- phenylcycl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 71 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360342![]() (US9828369, Example 3 | methyl 3-(8-(((1R,2R)-2- ph...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 82.7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360337![]() (US9828369, Example 2 | methyl 3-(8-((2-(4-(trifluo...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 85.6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360343![]() (US9828369, Example 4 | methyl 3-(8-((2-(3-methyl-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 96.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360348![]() (US9828369, Example 5 | methyl 3-(8-((1-(4-(trifluo...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360433![]() (US9828369, Example 6 | methyl 3-(8-((2-(4-phenoxyp...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 101 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360434![]() (US9828369, Example 7 | methyl 3-(8-((3-(tert-butyl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360444![]() (N-((5-(3-ethoxyphenyl)isoquinolin- 8-yl)methyl)-2-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 115 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360600![]() (1-([1,1'-biphenyl]-3-yl)-3-((5(3- methoxyphenyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 116 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360585![]() ((R/S)-2-(6-methoxynaphthalen-2-yl)- N-((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 118 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360435![]() (US9828369, Example 8 | methyl 3-(8-((1-phenyl-5- (...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 123 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360436![]() (US9828369, Example 9 | methyl 3-(8-((1-methyl-3-pr...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 132 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360437![]() (US9828369, Example 10 | methyl 3-(8-((spiro[2.4]he...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 162 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360438![]() (8-((isoquinoline-1- carboxamido)methyl)-5-(3- (met...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 164 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360545![]() (2-(4-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 178 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360439![]() (8-((isoquinoline-5- carboxamido)methyl)-5-(3- (me...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 196 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360586![]() (2-(6-methoxynaphthalen-2-yl)-N-((5- (3-methoxyphen...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 197 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360595![]() (1-(2,3-dichlorophenyl)-3-((5-(3,5- dimethoxyphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 198 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360613![]() (US9828369, Example 172) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 206 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360582![]() (2-(2-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 213 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360542![]() (2-(3-bromophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360543![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)sp...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 243 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360579![]() (2-(4-cyanophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 256 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360573![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)bi...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 268 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360447![]() (N-((5-(3- (methoxymethyl)phenyl)isoquinolin- 8-yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 278 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360489![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 291 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360581![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 298 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360537![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 305 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360498![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 306 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360484![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 317 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360588![]() ((R/S)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)- N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 319 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360577![]() (2-([1,1'-biphenyl]-4-yl)-N-((5-(3- methoxyphenyl)i...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 324 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360569![]() ((R/S)-2-(3-fluoro-4- (trifluoromethyl)phenyl)-N-((...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 373 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360601![]() (1-(2,3-dichlorophenyl)-3-((5-(1- phenylyinyl)isoqu...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 374 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360574![]() (5-bromo-2-fluoro-N-((5-(3- methoxyphenyl)isoquinol...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 400 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360593![]() (N-((5-(3-methoxyphenyl)quinolin- 8-yl)methyl)-2-(4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 426 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360602![]() (1-(2,3-dichlorophenyl)-3-((5-(3- methoxypropyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 478 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360509![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 479 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360524![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360547![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 483 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360580![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 484 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360566![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 513 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360451![]() ((1S,2S)-2-(4-methoxyphenyl)-N-((5- (3-methoxypheny...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 537 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360553![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 544 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360502![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360584![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 566 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360576![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 571 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360452![]() ((cis)-2-(4-methoxyphenyl)-N-((5-(3- methoxyphenyl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 589 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360551![]() ((trans)-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 589 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360540![]() (2-(4-chlorophenyl)-N-((5-(3 methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 597 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360505![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 602 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360525![]() (2'-hydroxy-N-((5-(3- methoxyphenyl)isoquinolin-8-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 602 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360507![]() (2-(2-(4-fluorophenyl)thiazol-4-yl)-N- ((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 609 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360583![]() ((R/S)-2-(2-fluoro-[1,1'-biphenyl]-4-yl)- N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 624 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360552![]() (2-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 696 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360472![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)qu...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 745 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360504![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 758 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360457![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 818 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360458![]() (2-(2,3-dichlorophenyl)-N-((5-(3- methoxyphenyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 883 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360448![]() (N-((5-(3- isopropoxyphenyl)isoquinolin-8- yl)methy...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 888 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360534![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 889 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360533![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 902 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360544![]() (2-(2-bromophenyl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 915 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360589![]() ((R/S)-2-(4-isobutylphenyl)-N-((5-(3- methoxyphenyl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 923 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360594![]() (US9828369, Example 151) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 938 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360560![]() (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 942 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360571![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 952 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360592![]() ((R/S)-2-(3,5- bis(trifluoromethyl)phenyl)-N-((5-(3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 974 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360527![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 988 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360490![]() (2-(2-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 993 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360596![]() (US9828369, Example 153 | methyl 2-(3-((5-(3- metho...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360555![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360546![]() (1-((4-chlorophenyl)sulfonyl)-N-((5-(3- methoxyphen...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360550![]() (2-(3-methoxyphenyl)-N-((5-(3- methoxyphenyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360564![]() (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360590![]() (2-(3,5-bis(trifluoromethyl)phenyl)-N- ((5-(3-metho...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360530![]() (3'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360603![]() (3-(8-((3-(2,3- dichlorophenyl)ureido)methyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.21E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360520![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360441![]() (US9828369, Example 13 | methyl 3-(8-((1-methyl-1H-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360554![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360521![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360517![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360464![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)ox...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360538![]() (US9828369, Example 95 | tert-butyl 3-(2-(((5-(3- m...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360485![]() (2-(4-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360529![]() (4'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360570![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360471![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.43E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360526![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360531![]() (3'-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- y...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.56E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360470![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360499![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.64E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360511![]() (3-(3,5-dimethyl-1H-pyrazol-1-yl)-N- ((5-(3-methoxy...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360494![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.75E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360535![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360456![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.77E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360449![]() (US9828369, Example 20 | isopropyl 3-(8-((2- phenyl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360510![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360604![]() (US9828369, Example 162 | tert-butyl 4-(8-((3-(2,3-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.95E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360598![]() (US9828369, Example 155 | methyl 3-(8-((3-(2,3- dic...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360491![]() (2-(2-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360508![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360578![]() (2-(3-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360459![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)q...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360453![]() (5-cyclopropyl-N-((5-(3- methoxyphenyl)isoquinolin-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360503![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.14E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360496![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.16E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360532![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360513![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360567![]() (2-fluoro-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.33E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360605![]() (3-(4-(8-((3-(2,3- dichlorophenyl)ureido)methyl)iso...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360523![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360568![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360587![]() ((cis)-N-((5-(3-methoxyphenyl) isoquinolin-8-yl)met...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.56E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360497![]() (2-(3-chlorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360572![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360463![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360506![]() (2-(2,3-dihydrobenzo[b][1,4]dioxin-6- yl)-N-((5-(3-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360465![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)ox...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360597![]() (N-((5-(3-methoxyphenyl)isoquinolin-8- yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360558![]() (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360561![]() (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360460![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360512![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360462![]() (3-ethyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360445![]() ((trans)-N-((5-(3- cyanophenyl)isoquinolin-8-yl)met...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360469![]() ((R/S)-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)me...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.55E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360528![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360495![]() (2-(3-fluorophenyl)-N-((5-(3- methoxyphenyl)isoquin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.71E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360446![]() (2-phenyl-N-((5-(3- (trifluoromethoxy)phenyl)isoqui...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.76E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360515![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360455![]() (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360575![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.94E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360514![]() (2-((5-hydroxy-1,2,3-oxadiazol-3(2H)- yl)methyl)-N-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360606![]() (1-(2,3-dichlorophenyl)-3-((5-(1- phenylethyl)isoqu...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.22E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360563![]() (5-bromo-N-((5-(3- methoxyphenyl)isoquinolin-8- yl)...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.24E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360607![]() (US9828369, Example 165 | tert-butyl 3-(8-((3-(2,3-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360608![]() (1-(2,3-dichlorophenyl)-3-((5-(3- (morpholine-4- ca...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360609![]() (1-(2,3-dichlorophenyl)-3-((5-(2,5- dihydro-1H-pyrr...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.42E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360500![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360519![]() (4-(isoxazol-3-yl)-N-((5-(3- methoxyphenyl)isoquino...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360516![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.84E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360556![]() (1-benzyl-N-((5-(3- methoxyphenyl)isoquinolin-8- yl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360562![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360467![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)qu...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360557![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360450![]() (3-(8-((2- phenylcyclopropanecarboxamido) methyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360536![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360454![]() (3-(furan-2-yl)-N-((5-(3- methoxyphenyl)isoquinolin...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.83E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360591![]() (2-(3-chloro-4-cyclohexylphenyl)-N- ((5-(3-methoxyp...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360610![]() (1-([1,1'-biphenyl]-2-yl)-3-((5-(3- methoxyphenyl)i...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360565![]() (2-(5-bromopyridin-3-yl)-N-((5-(3- methoxyphenyl)is...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360501![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360461![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-3...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.36E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360541![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)sp...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360548![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-2...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360599![]() (US9828369, Example 156 | ethyl 3-(8-((3-(2,3-dichl...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360468![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.78E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360539![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360559![]() (2-(5-bromopyridin-2-yl)-2,2-difluoro- N-((5-(3-met...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.13E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360611![]() (1-(2,4-difluorophenyl)-3-((5-(3- methoxyphenyl)qui...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360522![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-1...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.49E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360612![]() (1-(2,3-dichlorophenyl)-3-((5-(3- methoxyphenyl)qui...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.02E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360518![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-5...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360466![]() (N-((5-(3-methoxyphenyl)isoquinolin- 8-yl)methyl)-4...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Diacylglycerol O-acyltransferase 2 (Homo sapiens (Human)) | BDBM360451![]() ((1S,2S)-2-(4-methoxyphenyl)-N-((5- (3-methoxypheny...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.96E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharpe & Dohme Corp. US Patent | Assay Description DGAT2 activity was determined by measuring the amount of enzymatic product triolein (1,2,3-Tri(cis-9-octadecenoyl)glycerol) using the membrane prep m... | US Patent US9828369 (2017) BindingDB Entry DOI: 10.7270/Q2DN47C7 | |||||||||||
More data for this Ligand-Target Pair |